P
Piergiorgio Solli
Researcher at Academy for Urban School Leadership
Publications - 171
Citations - 3101
Piergiorgio Solli is an academic researcher from Academy for Urban School Leadership. The author has contributed to research in topics: Lung cancer & Pneumonectomy. The author has an hindex of 28, co-authored 149 publications receiving 2540 citations. Previous affiliations of Piergiorgio Solli include Papworth Hospital & European Institute of Oncology.
Papers
More filters
Journal ArticleDOI
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Marina Chiara Garassino,Jennifer G. Whisenant,Li-Ching Huang,Annalisa Trama,Valter Torri,Francesco Agustoni,Javier Baena,Giuseppe Luigi Banna,Rossana Berardi,Anna Cecilia Bettini,Emilio Bria,Matteo Brighenti,Jacques Cadranel,Alessandro De Toma,Claudio Chini,Alessio Cortellini,Enriqueta Felip,Giovanna Finocchiaro,Pilar Garrido,Carlo Genova,Raffaele Giusti,Vanesa Gregorc,Francesco Grossi,Federica Grosso,Salvatore Intagliata,Nicla La Verde,Stephen V. Liu,Julien Mazieres,Edoardo Mercadante,Olivier Michielin,Gabriele Minuti,Denis Moro-Sibilot,Giulia Pasello,Antonio Passaro,Vieri Scotti,Piergiorgio Solli,Elisa Stroppa,Marcello Tiseo,Giuseppe Viscardi,Luca Voltolini,Yi-Long Wu,Silvia Zai,Vera Pancaldi,Anne Marie C. Dingemans,Jan P. van Meerbeeck,Fabrice Barlesi,Heather A. Wakelee,Solange Peters,Leora Horn +48 more
TL;DR: With an ongoing global pandemic of COVID-19, the data suggest high mortality and low admission to intensive care in patients with thoracic cancer and whether mortality could be reduced with treatment in intensive care remains to be determined.
Journal ArticleDOI
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Giulia Veronesi,Massimo Bellomi,Massimo Bellomi,James L. Mulshine,Giuseppe Pelosi,Giuseppe Pelosi,Paolo Scanagatta,Giovanni Paganelli,Patrick Maisonneuve,Lorenzo Preda,Francesco Leo,Raffaella Bertolotti,Piergiorgio Solli,Lorenzo Spaggiari,Lorenzo Spaggiari +14 more
TL;DR: The protocol limits invasive diagnostic procedures while few patients have diagnosis delay, supporting the feasibility of lung cancer screening in high-risk subjects by LD-CT and further optimization of the clinical management of screening-detected nodules is necessary.
Journal ArticleDOI
A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases".
Monica Casiraghi,Tommaso De Pas,Patrick Maisonneuve,Daniela Brambilla,Barbara Ciprandi,Domenico Galetta,Alessandro Borri,Roberto Gasparri,Francesco Petrella,Adele Tessitore,Juliana Guarize,Stefano Donghi,Giulia Veronesi,Piergiorgio Solli,Lorenzo Spaggiari +14 more
TL;DR: The validity of the International Registry of Lung Metastases classification system in patients who underwent curative lung metastasectomy in a single center was confirmed and completeness of surgery, histology, and DFI ≥36 months as independent prognostic factors were confirmed.
Journal ArticleDOI
EACTS expert consensus statement for surgical management of pleural empyema
Marco Scarci,Udo Abah,Piergiorgio Solli,Aravinda Page,David A. Waller,Paul Van Schil,Franca Melfi,Ralph A. Schmid,Kalliopi Athanassiadi,Miguel Sousa Uva,Giuseppe Cardillo +10 more
TL;DR: The current literature cements the role of VATS in the management of pleural empyema, even if the choice of surgical approach relies on the individual surgeon's preference.
Journal ArticleDOI
Superior Vena Cava Resection for Lung and Mediastinal Malignancies: A Single-Center Experience With 70 Cases
Lorenzo Spaggiari,Francesco Leo,Giulia Veronesi,Piergiorgio Solli,Domenico Galetta,Brunilda Tatani,Francesco Petrella,Davide Radice +7 more
TL;DR: SVC resection may achieve permanent cure in patients who would have been defined as inoperable 10 years ago and should not be considered a contraindication for surgery when prosthetic replacement is feasible, and infiltration of SVC can achieve satisfactory long-term results after neoadjuvant chemotherapy.